AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Waste (hazardous/solid/interstate/nuclear) WAS
Communication to the Environmental Protection Agency on Preliminary 2010 Effluent Guidelines Program Plan and the disposal of unused pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTINE COFFEY | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| GERALYN TRUJILLO | — |
Health Issues HCR
Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III, all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communications to House and Senate supporting residency funding. Communicatins with FDA regarding the Safe Use Initiative; Communications with FDA regarding inpatient distribution of Medication Guides; Communication with FDA on Transparency Task Force; Communication with FDA on appointment of Special Government Employees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTINE COFFEY | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| GERALYN TRUJILLO | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services on chemotherapy administration codes, physician supervision requirements, and anticoagulation billing issue; Communications to CMS and Office of the National Coordinator for Health Information Technology on issues relating to health information technology and meaningful use.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTINE COFFEY | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| GERALYN TRUJILLO | — |
Pharmacy PHA
Communication with FDA regarding the quality of compounded drugs and improving stakeholder communications; Communications to the Agency for Healthcare Research and Quality regarding nominations to Effective Healthcare Stakeholder Group; Communication with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act Reauthorization Public Meeting.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUSTINE COFFEY | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| GERALYN TRUJILLO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.